- title: General Information
  type: map
  contents:
    - name: Full Name
      value: Zehua Wang (Zack Wang)
    - name: Date of Birth
      value: 23rd May 2000
    - name: Languages
      value: English, Chinese, Cantonese, Japanese

- title: Education
  type: time_table
  contents:
    - title: Master’s Degree in Pharmacokinetics
      institution: China Pharmaceutical University, Nanjing, China
      year: Expected 2025
      description:
        - "GPA: 3.8/4.0"
        - "IELTS: 6.5, CET-6: 567"
        - "Main research experience 1: ADC Drug Modeling and Analysis: Led the development of whole-body PBPK, semi-PBPK, and PD models for Antibody-Drug Conjugates (ADCs), identifying key factors influencing pharmacokinetics, pharmacodynamics, and toxicity. Conducted virtual population-based clinical trials, focusing on sensitivity analysis, optimizing dosing strategies, and mitigating clinical toxicities. Software: Monolix, Phoenix Winnonlin, Berkeley Madonna, PK-Sim, R."
        - "Main research experience 2: Alzheimer’s Antibody Therapy Pop-PKPD Models: Spearheaded the development of population PKPD models, incorporating disease progression models for Alzheimer's disease patients. Analyzed the relationship between drug exposure and biomarkers to optimize personalized treatments."
        - "Main research experience 3: Drug Metabolism and Transport Mechanisms: Investigated interactions between transporters and metabolic enzymes under pathological conditions affecting the CNS, integrating molecular biology techniques with advanced data analysis."
        - "Main research experience 4: Phase I NSAID Clinical Pharmacometrics Study: In collaboration with industry, led a pharmacometrics study on novel NSAIDs, overseeing data modeling, parameter estimation, physicochemical property characterization, and optimization of therapeutic regimens."

    - title: Bachelor of Engineering in Pharmaceutical Engineering
      institution: Shandong First Medical University, Jinan, China
      year: 2022
      description:
        - "Average Score: 83.5/100"
        - "CET-4: 592"
        - "Main research experience: Prepared various MOF-derived carbon materials for water purification tests and compared their performance under different conditions."

- title: Honors and Awards
  type: time_table
  contents:
    - year: 2024
      items:
        - "Exploring the World Scholarship, CPU: Awarded for excellence in academic performance and research contributions, supporting international exposure and collaboration in pharmaceutical studies."
    - year: 2022-2024
      items:
        - "Outstanding League Member, CPU: Recognized for leadership and exceptional contributions to student activities and community engagement."
        - "Scholarship of Academic Excellence, CPU: Granted for consistently outstanding academic performance and research achievements in the field of pharmacokinetics."
    - year: 2022
      items:
        - "Outstanding Graduate, SDFMU: Honored as one of the top-performing graduates, reflecting academic excellence and research contributions in pharmaceutical engineering."
    - year: 2020-2021
      items:
        - "Prize Scholarship, SDFMU: Awarded for high academic performance and involvement in research projects, particularly in the development of novel drug delivery systems."

- title: Academic Interests
  type: nested_list
  contents:
    - title: Pharmacometrics
      items:
        - "PK-PD (pharmacokinetics and pharmacodynamics) and Population Modeling: Optimizes drug design, predicts efficacy and safety, and addresses target-mediated drug disposition. Population PK/PD helps assess patient variability and supports cross-species scaling for clinical trials and precision medicine."
        - "QSP (Quantitative Systems Pharmacology): Integrates mechanistic models with PK/PD data to guide drug development, optimize dosing, and enhance understanding of complex biological systems."
        - "Immunogenicity: Addresses immune responses and nonlinear kinetics in large molecule drugs, ensuring therapeutic outcomes in clinical and industrial applications."
        - "Regulatory and Clinical Exemptions: Supports regulatory submissions and potentially streamlines clinical trials with trial exemptions, accelerating drug development and approval."
        - "Web-based Models: Used for simulating drug behavior, visualizing results, and facilitating real-time decision-making in collaboration with clinicians and regulators."
    - title: Pharmacology and Pathology
      items:
        - "Drug Transport and BBB Interaction: Investigated transporters' roles (e.g., OCTs, MATE1) in drug disposition across the blood-brain barrier, focusing on how peripheral diseases like liver pathology affect CNS drug exposure."
        - "CNS Pharmacokinetics and Drug Metabolism: Explored CNS drug distribution and efficacy in the context of metabolic changes in peripheral organs."
        - "Peripheral Organ Pathology and CNS Dysfunction: Examined the impact of peripheral diseases, like liver injury, on CNS drug metabolism using in vivo and in vitro models."
        - "Neuroprotective Drug Development: Researched the development of drugs aimed at protecting CNS function, particularly in cases where peripheral pathology leads to secondary CNS damage."
        - "Cancer Therapy with Large Molecule Drugs: Focused on developing and optimizing Antibody-Drug Conjugates (ADCs) for the treatment of cancers such as breast and gastric cancer, with an emphasis on PK-PD and clinical outcomes."
- title: Other Interests
  type: list
  contents:
    - "Hobbies: Photography and Filmmaking: Experienced in photography and micro-movie production, having received multiple provincial and school-level awards. Skilled in new media management and content creation."
    - "Chess: Over 10 years of competitive chess experience, with a history of winning various provincial chess competitions."
    - "Sports: Proficient in swimming, table tennis, and badminton, with a focus on maintaining a healthy balance between academics and physical activities."
